After the discovery of cisplatin, many metal compounds were investigated for the therapy of
diseases, especially cancer. The high therapeutic potential of metal-based compounds is …

Conclusion We very much appreciated working with all the authors noted above on
assembling this special issue and we hope that you enjoy reading their excellent …

Metal complexes have been the subject of numerous investigations in oncology but, despite
the plethora of newly synthesized compounds, their precise mechanisms of action remain …

Guest editors Enzo Alessio and Zijian Guo present an overview of the topics reported in the
papers of this issue, listing the general trends that dominate the field of metal anticancer …

Since the discovery of cisplatin more than 40 years ago, enormous research efforts have
been dedicated to developing metal-based anticancer agents and to elucidating the …

Metal-based antitumor drugs play a relevant role in antiblastic chemotherapy. Cisplatin is
regarded as one of the most effective drugs, even if severe toxicities and drug resistance …

Metal complexes in cancer therapy have attracted much interest mainly because metals
exhibit unique characteristics, such as redox activity, metal‐ligand interaction, structure and …

Since the initial discovery of applications of platinum complexes in the clinical treatment of
many kinds of cancers, the efficiency of platinum complexes in inhibiting the proliferation of …

The research and development of metal supramolecular complexes as anticancer
supramolecular drugs, which are aggregates mainly formed by one or more inorganic metal …

Metal-based complexes have demonstrated significant anticancer effects and have emerged
as candidates with great potential for cancer therapy. These agents are effective in a variety …